Isthmus Partners’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-50,110
Closed -$1.71M 206
2024
Q1
$1.71M Sell
50,110
-25,651
-34% -$875K 0.19% 109
2023
Q4
$2.19M Buy
75,761
+11,289
+18% +$327K 0.29% 79
2023
Q3
$1.78M Buy
64,472
+1,858
+3% +$51.2K 0.26% 89
2023
Q2
$1.88M Sell
62,614
-292
-0.5% -$8.78K 0.26% 86
2023
Q1
$2.28M Buy
62,906
+693
+1% +$25.1K 0.32% 64
2022
Q4
$2.22M Buy
62,213
+159
+0.3% +$5.67K 0.33% 60
2022
Q3
$2.1M Buy
62,054
+2,700
+5% +$91.4K 0.36% 57
2022
Q2
$1.72M Buy
59,354
+1,791
+3% +$51.8K 0.32% 70
2022
Q1
$1.86M Buy
57,563
+3,107
+6% +$100K 0.31% 70
2021
Q4
$1.59M Buy
54,456
+947
+2% +$27.6K 0.27% 88
2021
Q3
$1.43M Buy
53,509
+2,528
+5% +$67.4K 0.26% 91
2021
Q2
$1.57M Buy
50,981
+1,000
+2% +$30.8K 0.28% 84
2021
Q1
$1.31M Buy
49,981
+942
+2% +$24.7K 0.24% 98
2020
Q4
$1.23M Sell
49,039
-236
-0.5% -$5.94K 0.25% 92
2020
Q3
$1.03M Buy
49,275
+5,018
+11% +$105K 0.24% 84
2020
Q2
$1.05M Buy
44,257
+4,179
+10% +$99.2K 0.26% 79
2020
Q1
$721K Sell
40,078
-1,126
-3% -$20.3K 0.22% 83
2019
Q4
$977K Buy
41,204
+2,405
+6% +$57K 0.22% 94
2019
Q3
$1.07M Buy
38,799
+7,635
+24% +$210K 0.25% 86
2019
Q2
$1.03M Buy
31,164
+9,196
+42% +$304K 0.25% 83
2019
Q1
$1.36M Sell
21,968
-5,468
-20% -$340K 0.33% 56
2018
Q4
$911K Buy
27,436
+2,736
+11% +$90.8K 0.27% 80
2018
Q3
$1.24M Buy
24,700
+118
+0.5% +$5.94K 0.31% 53
2018
Q2
$1.47M Sell
24,582
-743
-3% -$44.5K 0.38% 48
2018
Q1
$1.16M Sell
25,325
-50
-0.2% -$2.29K 0.31% 52
2017
Q4
$1.01M Sell
25,375
-87
-0.3% -$3.47K 0.28% 62
2017
Q3
$1.02M Sell
25,462
-1,078
-4% -$43.1K 0.29% 61
2017
Q2
$1.14M Sell
26,540
-421
-2% -$18.1K 0.33% 49
2017
Q1
$844K Buy
+26,961
New +$844K 0.25% 72